Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 24 August 2010
Vol. 3, Issue 136, p. ra64
[DOI: 10.1126/scisignal.2000998]
RESEARCH ARTICLES
Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases
Albrecht Moritz1*,
Yu Li1*,
Ailan Guo1*,
Judit Villén2*,
Yi Wang1,
Joan MacNeill1,
Jon Kornhauser1,
Kam Sprott1,
Jing Zhou1,
Anthony Possemato1,
Jian Min Ren1,
Peter Hornbeck1,
Lewis C. Cantley3,4,
Steven P. Gygi2,
John Rush1, and
Michael J. Comb1
1 Cell Signaling Technology Inc., 3 Trask Lane, Danvers, MA 01923, USA. 2 Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. 3 Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. 4 Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
* These authors contributed equally to this work.
Present address: Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Abstract:
Receptor tyrosine kinases (RTKs) activate pathways mediated by serine-threonine kinases, such as the PI3K (phosphatidylinositol 3-kinase)–Akt pathway, the Ras–MAPK (mitogen-activated protein kinase)–RSK (ribosomal S6 kinase) pathway, and the mTOR (mammalian target of rapamycin)–p70 S6 pathway, that control important aspects of cell growth, proliferation, and survival. The Akt, RSK, and p70 S6 family of protein kinases transmits signals by phosphorylating substrates on an RxRxxS/T motif (R, arginine; S, serine; T, threonine; and x, any amino acid). We developed a large-scale proteomic approach to identify more than 300 substrates of this kinase family in cancer cell lines driven by the c-Met, epidermal growth factor receptor (EGFR), or platelet-derived growth factor receptor (PDGFR) RTKs. We identified a subset of proteins with RxRxxS/T sites for which phosphorylation was decreased by RTK inhibitors (RTKIs), as well as by inhibitors of the PI3K, mTOR, and MAPK pathways, and we determined the effects of small interfering RNA directed against these substrates on cell viability. Phosphorylation of the protein chaperone SGTA (small glutamine-rich tetratricopeptide repeat–containing protein ) at serine-305 was essential for PDGFR stabilization and cell survival in PDGFR-dependent cancer cells. Our approach provides a new view of RTK and Akt–RSK–S6 kinase signaling, revealing previously unidentified Akt–RSK–S6 kinase substrates that merit further consideration as targets for combination therapy with RTKIs.
To whom correspondence should be addressed. E-mail: mcomb{at}cellsignal.com
Citation: A. Moritz, Y. Li, A. Guo, J. Villén, Y. Wang, J. MacNeill, J. Kornhauser, K. Sprott, J. Zhou, A. Possemato, J. M. Ren, P. Hornbeck, L. C. Cantley, S. P. Gygi, J. Rush, M. J. Comb, Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases. Sci. Signal.3, ra64 (2010).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (15 May 2012) Sci. Signal.5 (224), ec135.
[DOI: 10.1126/scisignal.2003217] |Abstract »
EDITORIAL GUIDES
Nancy R. Gough (27 March 2012) Sci. Signal.5 (217), eg4.
[DOI: 10.1126/scisignal.2003044] |Abstract »|Full Text »|PDF »
EDITORIAL GUIDES
Nancy R. Gough (6 September 2011) Sci. Signal.4 (189), eg8.
[DOI: 10.1126/scisignal.2002478] |Abstract »|Full Text »|PDF »
PRESENTATIONS
Illés J. Farkas, Tamás Korcsmáros, István A. Kovács, Ágoston Mihalik, Robin Palotai, Gábor I. Simkó, Kristóf Z. Szalay, Máté Szalay-Beko, Tibor Vellai, Shijun Wang, and Peter Csermely (17 May 2011) Sci. Signal.4 (173), pt3.
[DOI: 10.1126/scisignal.2001950] |Abstract »|Full Text »|PDF »|Slideshow »
EDITORIAL GUIDES
Elizabeth M. Adler and Nancy R. Gough (29 March 2011) Sci. Signal.4 (166), eg3.
[DOI: 10.1126/scisignal.2002014] |Abstract »|Full Text »|PDF »
EDITORIAL GUIDES
Elizabeth M. Adler (4 January 2011) Sci. Signal.4 (154), eg1.
[DOI: 10.1126/scisignal.2001770] |Abstract »|Full Text »|PDF »
EDITORIAL GUIDES
Nancy R. Gough and John F. Foley (31 August 2010) Sci. Signal.3 (137), eg6.
[DOI: 10.1126/scisignal.3137eg6] |Abstract »|Full Text »|PDF »
PODCASTS
Michael J. Comb and Annalisa M. VanHook (24 August 2010) Sci. Signal.3 (136), pc17.
[DOI: 10.1126/scisignal.3136pc17] |Abstract »|Full Text »|Podcast »
Systematic analysis of the Plk-mediated phosphoregulation in eukaryotes.
Z. Liu, J. Ren, J. Cao, J. He, X. Yao, C. Jin, and Y. Xue (2013)
Brief Bioinform
14, 344-360
|Abstract »|Full Text »|PDF »
Phosphoproteomic Analysis Implicates the mTORC2-FoxO1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases.
G. Zhuang, K. Yu, Z. Jiang, A. Chung, J. Yao, C. Ha, K. Toy, R. Soriano, B. Haley, E. Blackwood, et al. (2013)
Science Signaling
6, ra25
|Abstract »|Full Text »|PDF »
JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells.
Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover.
J. M. Bristow, T. A. Reno, M. Jo, S. L. Gonias, and R. L. Klemke (2013)
J. Biol. Chem.
288, 123-131
|Abstract »|Full Text »|PDF »
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.
I.-T. J. Wang, M. Allen, D. Goffin, X. Zhu, A. H. Fairless, E. S. Brodkin, S. J. Siegel, E. D. Marsh, J. A. Blendy, and Z. Zhou (2012)
PNAS
109, 21516-21521
|Abstract »|Full Text »|PDF »
Extracellular Phosphorylation and Phosphorylated Proteins: Not Just Curiosities But Physiologically Important.
Modified SH2 domain to phototrap and identify phosphotyrosine proteins from subcellular sites within cells.
A. Uezu, H. Okada, H. Murakoshi, C. D. del Vescovo, R. Yasuda, D. Diviani, and S. H. Soderling (2012)
PNAS
109, E2929-E2938
|Abstract »|Full Text »|PDF »
Cardiac mitochondrial matrix and respiratory complex protein phosphorylation.
R. Covian and R. S. Balaban (2012)
Am J Physiol Heart Circ Physiol
303, H940-H966
|Abstract »|Full Text »|PDF »
The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation.
H. J. Jun, H. Johnson, R. T. Bronson, S. de Feraudy, F. White, and A. Charest (2012)
Cancer Res.
72, 3764-3774
|Abstract »|Full Text »|PDF »
Regulatory Effects of Programmed Cell Death 4 (PDCD4) Protein in Interferon (IFN)-Stimulated Gene Expression and Generation of Type I IFN Responses.
B. Kroczynska, B. Sharma, E. A. Eklund, E. N. Fish, and L. C. Platanias (2012)
Mol. Cell. Biol.
32, 2809-2822
|Abstract »|Full Text »|PDF »
PTMScan Direct: Identification and Quantification of Peptides from Critical Signaling Proteins by Immunoaffinity Enrichment Coupled with LC-MS/MS.
M. P. Stokes, C. L. Farnsworth, A. Moritz, J. C. Silva, X. Jia, K. A. Lee, A. Guo, R. D. Polakiewicz, and M. J. Comb (2012)
Mol. Cell. Proteomics
11, 187-201
|Abstract »|Full Text »|PDF »
LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNF{alpha} Expression and Receptor Tyrosine Kinase Signaling.
L. Bai, D. McEachern, C.-Y. Yang, J. Lu, H. Sun, and S. Wang (2012)
Cancer Res.
72, 1229-1238
|Abstract »|Full Text »|PDF »
Tyrosine Phosphorylation of the G{alpha}-Interacting Protein GIV Promotes Activation of Phosphoinositide 3-Kinase During Cell Migration.
C. Lin, J. Ear, Y. Pavlova, Y. Mittal, I. Kufareva, M. Ghassemian, R. Abagyan, M. Garcia-Marcos, and P. Ghosh (2011)
Science Signaling
4, ra64
|Abstract »|Full Text »|PDF »
Phosphoproteomic Analysis of Salmonella-Infected Cells Identifies Key Kinase Regulators and SopB-Dependent Host Phosphorylation Events.
L. D. Rogers, N. F. Brown, Y. Fang, S. Pelech, and L. J. Foster (2011)
Science Signaling
4, rs9
|Abstract »|Full Text »|PDF »
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H2O2.
V. Cenni, A. Bavelloni, F. Beretti, F. Tagliavini, L. Manzoli, G. Lattanzi, N. M. Maraldi, L. Cocco, and S. Marmiroli (2011)
Mol. Biol. Cell
22, 2946-2956
|Abstract »|Full Text »|PDF »
Combinatorial Treatments That Overcome PDGFR{beta}-Driven Resistance of Melanoma Cells to V600EB-RAF Inhibition.